EUVIMEDEUVIMED entdecken
Multizentrische Studie

Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib

Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, Katsuhiko Masudo, Soji Toda, Aya Saito

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-025-04824-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Haruhiko Yamazaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafunecho, Minami-ku, Minamiku, Yokohama City, 232-0024, Kan…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Thyroglobulin. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsThyroglobulinHumansOximesMalePyridonesFemalePyrimidinonesImidazolesMiddle AgedRetrospective StudiesProto-Oncogene Proteins B-rafAdultAgedMutation

Stichwörter der Autor:innen

DabrafenibDifferentiated thyroid carcinomaThyroglobulinTrametinib

Substanzen

trametinibdabrafenibOximesPyridonesPyrimidinonesImidazolesProto-Oncogene Proteins B-rafThyroglobulinBRAF protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafunecho, Minami-ku, Minamiku, Yokohama City, 232-0024, Kanagawa, Japan. yamazaki.har.zo@yokohama-cu.ac.jp.
  • Department of Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama City, 236-0004, Kanagawa, Japan.
  • Department of Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama City, 241-8515, Kanagawa, Japan.
  • Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafunecho, Minami-ku, Minamiku, Yokohama City, 232-0024, Kanagawa, Japan.

Zitieren

APA

Yamazaki, H., Suganuma, N., Kadoya, M., Masudo, K., Toda, S., & Saito, A. (2025). Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-025-04824-2

Vancouver

Yamazaki H, Suganuma N, Kadoya M, Masudo K, Toda S, Saito A. Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-025-04824-2

BibTeX
@article{Yamazaki2025,
  author = {Yamazaki, Haruhiko and Suganuma, Nobuyasu and Kadoya, Mei and Masudo, Katsuhiko and Toda, Soji and Saito, Aya},
  title = {Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-025-04824-2}
}
Kostenlos starten →